What is Entavir 0.5?
Entavir 0.5 is an antiviral therapy containing the active ingredient Entecavir. It is used to treat Hepatitis B infection and the complications associated with it. This drug controls the viral load in the body and mainly protects the liver from viral damage.
Chronic Hepatitis B (CHB)
This condition occurs when the hepatitis B virus (HBV) persists in liver cells for a long time, which can silently damage the liver. Entavir 0.5 decreases the viral load in the body, reduces inflammation, and maintains liver function.
Compensated liver disease due to HBV
At this stage, the liver is damaged. However, it can still carry out its function, although at a lower efficiency. Entavir 0.5, by lowering the viral activity, reduces the strain on the liver and helps maintain stable liver function.
Decompensated liver disease due to HBV
In this case, the liver function is severely impaired, which leads to symptoms like fluid accumulation (ascites), jaundice, and weakness. Entavir 0.5 is used for this indication as it helps restore liver function.
Lamivudine-resistant HBV infection
Lamivudine is an oral antiviral medication that is also used in the treatment of HBV. However, some HBVs become resistant to this drug and can continue growing. Entavir 0.5 is used to eliminate such resistant HBVs and improve the patient’s condition.
Prevention of HBV reactivation
In some patients, the HBV can remain dormant and revive when the immune system is weak, or during chemotherapy. In such cases, Entavir 0.5 is used to prevent the relapse of the HBV from its dormant state.
Post–liver transplant HBV prophylaxis
After a liver transplant, if there is residual HBV in the host body, it can affect the newly transplanted liver. Entavir 0.5 is used as a prophylactic measure to protect the new liver from an HBV infection.
Standard Dosing
This dosing for Entavir is applicable for the treatment of:
This dosing is applicable for the following indications:
Entavir 0.5 consists of the active ingredient Entecavir, which is used exclusively for the treatment of Hepatitis B virus (HBV). It belongs to the class of guanosine nucleoside analogues, which is responsible for the antiviral mechanism of this drug.
Unlike bacterial pathogens, HBV multiplies using a unique replication process. It converts RNA into DNA with a viral enzyme, reverse transcriptase. This is followed by initiation of DNA replication (priming) and duplication of the newly formed DNA.
Entavir 0.5 inhibits the reverse transcriptase enzyme, preventing the formation of DNA for replication. It also mimics the natural nucleotide of the DNA- d-GTP, and enters the DNA in its place. Further, this drug also causes premature termination of the DNA chain, preventing it from replicating.
In this way, Entavir 0.5 targets three main mechanisms of viral replication and reduces the viral load.
1. Lactic acidosis (rare but life-threatening)
2. Hepatotoxicity/liver worsening
4. Renal effects
5. Hematological abnormalities
1.Does Entavir 0.5 cure HBV?
No. Entavir 0.5 controls the HBV load, but cannot cure it completely.
2.Can it be consumed with food?
Entavir 0.5 must be consumed on an empty stomach for the best effects.
3.Can pregnant women take Entavir 0.5?
Pregnant or breastfeeding women must only consume Entavir 0.5 if a medical professional deems it necessary.
4.Is Entavir 0.5 safe for long-term use?
Under medical guidance, Entavir 0.5 is safe for long-term use.
5.What are the critical side effects?
Patients must be regularly monitored for severe fatigue, yellowing of the eyes, and abdominal swelling.
